Svelte Medical Systems, Inc.
Svelte Medical Systems, Inc., headquartered in the United States, is a pioneering company in the medical device industry, specialising in innovative solutions for cardiovascular interventions. Founded in 2012, Svelte has made significant strides with its unique drug-eluting stent technology, designed to enhance patient outcomes while minimising complications. The company’s flagship products, including the Svelte DES (Drug-Eluting Stent) platform, stand out for their streamlined delivery system and reduced procedure times, setting new standards in interventional cardiology. With a strong presence in major operational regions across North America and Europe, Svelte Medical Systems has established itself as a leader in the field, recognised for its commitment to advancing minimally invasive treatments.
DitchCarbon Score
How does Svelte Medical Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Svelte Medical Systems, Inc.'s score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Svelte Medical Systems, Inc.'s reported carbon emissions
Svelte Medical Systems, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints and enhancing environmental responsibility. As the landscape of corporate climate commitments evolves, Svelte Medical Systems may consider establishing measurable targets in line with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Svelte Medical Systems, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
